Dasatinib as a bone-modifying agent: anabolic and anti-resorptive effects. [electronic resource]
Producer: 20120910Description: e34914 p. digitalISSN:- 1932-6203
- Anabolic Agents -- pharmacology
- Animals
- Bone Remodeling -- drug effects
- Bone Resorption -- metabolism
- CSK Tyrosine-Protein Kinase
- Cathepsin K -- metabolism
- Cell Differentiation -- drug effects
- Cell Line
- Cell Proliferation -- drug effects
- Dasatinib
- Female
- Humans
- Integrin alphaVbeta3 -- metabolism
- Leukocytes, Mononuclear -- cytology
- Mesenchymal Stem Cells -- cytology
- Mice
- NFATC Transcription Factors -- metabolism
- Osteoclasts -- cytology
- Phosphorylation
- Protein Kinase Inhibitors -- pharmacology
- Protein Serine-Threonine Kinases -- metabolism
- Protein-Tyrosine Kinases -- metabolism
- Proto-Oncogene Proteins c-kit -- metabolism
- Pyrimidines -- pharmacology
- Receptor, Platelet-Derived Growth Factor beta -- antagonists & inhibitors
- Thiazoles -- pharmacology
- Wnt Signaling Pathway
- src-Family Kinases
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.